Impact of PSMA PET Staging on Initial Treatment in Newly Diagnosed Prostate Cancer.

前列腺癌 医学 前列腺切除术 雄激素剥夺疗法 阶段(地层学) 谷氨酸羧肽酶Ⅱ 前列腺 放射治疗 随机对照试验 肿瘤科 生化复发 危险系数 泌尿科 放射科 比例危险模型 观察研究 前列腺特异性抗原 临床试验 核医学 荟萃分析 内科学
作者
Sean R. Miller,Dana H. Chung,Richard Gonzalez,Will Jackson,Megan E.V. Caram,Phoebe A. Tsao,Kristian Stensland,Roman Gulati,Yashesh Shah,Daniel J. Wale,David A. Elliott,Tanner Caverly,Timothy P. Hofer,Sameer D. Saini,Michael D. Green,Matthew J. Schipper,Robert T. Dess,Alex K. Bryant
出处
期刊:PubMed [National Institutes of Health]
卷期号:66 (12): 1891-1897
标识
DOI:10.2967/jnumed.125.270825
摘要

Prostate-specific membrane antigen (PSMA) PET/CT has become a common staging modality for newly diagnosed high-risk and unfavorable intermediate-risk prostate cancer after showing improved sensitivity and specificity compared with conventional imaging in clinical trials. We aimed to assess the causal impact of PSMA PET staging on initial treatment selection in real-world practice. Methods: We used observational data from the U.S. Veterans Health Administration to emulate a randomized controlled trial in which patients with newly diagnosed, unfavorable intermediate-, high-, and very-high-risk prostate cancer from January 2022 to December 2023 would have been randomized to undergo either upfront 18F- or 68Ga-PSMA PET staging or conventional imaging (99mTc bone scan and pelvic CT or MRI). Outcomes of interest included use of frontline androgen deprivation therapy (ADT), second-generation androgen receptor pathway inhibitors (ARPIs), radiotherapy, and radical prostatectomy. Weighted univariable Cox regression was performed to assess the effect of treatment group on each outcome, and 95% CIs were generated from 1,000 bootstrap replicates. Results: In total, 9,049 patients met the criteria for inclusion. PSMA PET staging was associated with higher rates of any ADT use relative to conventional staging (adjusted hazard ratio [aHR], 1.26; 95% CI, 1.19-1.44), higher rates of ARPI use (aHR, 1.52; 95% CI, 1.33-1.78), lower rates of prostatectomy (aHR, 0.69; 95% CI, 0.56-0.83), and no significant effect on the use of radiotherapy (aHR, 1.10; 95% CI, 0.99-1.25). Compared with patients with PSMA stage N0M0, ARPI use was more common in patients with PSMA stage N1M0 (aHR, 6.87; 95% CI, 5.41-8.73) and PSMA stage M1 (aHR, 10.13; 95% CI, 8.16-1.2.58). Patients with PSMA N1M0 disease were much less likely to undergo prostatectomy compared with PSMA N0M0. Conclusion: PSMA PET staging may be leading to fewer prostatectomies and higher use rates of ADT and ARPIs in the Veterans Health Administration.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
WX发布了新的文献求助10
1秒前
1秒前
2秒前
2秒前
小茗同学完成签到,获得积分10
2秒前
4秒前
5秒前
5秒前
5秒前
HZW完成签到 ,获得积分10
5秒前
Nole的应助被明亮的迎松采纳,获得10
6秒前
胖宝宝哈基米完成签到 ,获得积分10
7秒前
Hello的应助被Lu采纳,获得10
7秒前
felix发布了新的文献求助10
8秒前
9秒前
852的应助被一个橡果采纳,获得10
9秒前
无极微光的应助被甜美的雪冥采纳,获得20
10秒前
10秒前
赘婿的应助被燎原十八拍采纳,获得10
10秒前
longs完成签到,获得积分10
11秒前
12秒前
REALLY发布了新的文献求助30
12秒前
标致的千柳完成签到,获得积分10
13秒前
女孩完成签到,获得积分10
13秒前
CZ完成签到,获得积分10
14秒前
14秒前
14秒前
Jessy完成签到,获得积分10
14秒前
壮观雁易发布了新的文献求助10
15秒前
李健的小迷弟的应助被露露采纳,获得10
15秒前
研友_VZG7GZ的应助被yjt采纳,获得10
16秒前
16秒前
静坐听雨萧完成签到 ,获得积分10
17秒前
longs发布了新的文献求助20
17秒前
18秒前
Yuan88发布了新的文献求助10
18秒前
斯文败类的应助被明亮的迎松采纳,获得10
20秒前
箭剑尖完成签到,获得积分10
21秒前
Akim的应助被可可豆采纳,获得30
21秒前
严正桓完成签到 ,获得积分10
21秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8184220
求助须知:如何正确求助?哪些是违规求助? 9573266
关于积分的说明 21830447
捐赠科研通 7781246
什么是DOI,文献DOI怎么找? 3434248
关于科研通互助平台的介绍 2558373
邀请新用户注册赠送积分活动 2480784